Legal
Trouble for Wyeth & Pfizer, and Merck buys Schering-Plough
On March 4th, Wyeth and its suitor Pfizer received a wallop in a Supreme Court case of Wyeth v. Levine, in which a Vermont woman named Diana Levine was awarded $6.7 million in damages for an incident in which their antihistamine drug Phenergan (promethazine) may have led to loss of Levine’s arm due to gangrene. [...]
Compassionate Use for Investigational Drugs
In the Avelient BioPharm Blog article “A Brief FDA History Lesson“, Mariano Di Fabio provided some background on the events that lead to the establishment of the FDA’s current clinical trial framework, and he questioned if this framework should be changed so that experimental drugs could be released for use by terminally ill patients. Mariano [...]
Latest Tactics to Stifle Generic Competition
In the last half of this decade, it is estimated that $100 billion worth of brand name drugs have lost (or will lose) patent exclusivity. Each year, generic drugs take more and more of the market share from brand-name drug manufacturers. In fact, the percentage of drug prescriptions dispensed for generics increased from 47% to [...]
Pharmaceutical start-ups: Phytomedics
I read today about a really interesting pharmaceutical company that, though it’s considered a start-up, has spent the last 12 years researching and developing new drugs and methodologies that will allow for more rapid and safer development of drug products: Phytomedics. Their focus is on botanical drugs, which, in theory, could provide many of [...]
Ironing Out the Wrinkles
It’s late, and I’m sitting here at squinting at my computer screen most likely because I’ve positioned it too far away from my eyes. At least, that’s what I keep telling myself to make myself feel better.
I believe at some point in my life I will need glasses. I’ve been lucky so far, [...]
Loading ...